CAS Formulus Use Case - Montelukast Sodium

Pharmaceutical Industry Use Case

Developing medicines to treat asthma can be time consuming and a complex process. This is especially true in pediatric medicine where children prefer oral alternatives to inhalers. 

Formulators frequently start with baseline ingredient, montelukast sodium (CAS RN 151767-02-1) to make these drugs. To encourage patient compliance, it is necessary to include excipients specifically to help make montelukast sodium palatable.. Learn how Formulus can help speed up the process. 

Watch the Video

See how CAS Formulus® can be used as a single tool to address formulators concerns about factors such as shelf life, compatibility of ingredients, and regulatory issues.


Download the Use Case

Download the use case and learn how CAS Formulus can assist in development of formulations that ensure compatibility of ingredients, meet regulatory guidelines, and provide a product that meets patients needs.

Formulus Montelukast Sodium Use Case cover image

Formulus Information Request Form

Your privacy is important to CAS. More detail about how we use your information is in our privacy policy.